Laura Huber, DVM, MSc, PhD

Assistant Professor of Epidemiology

Laura Huber Photo
Contact
 

lzh0067@auburn.edu

Department of Pathobiology

Auburn University
College of Veterinary Medicine
1130 Wire Road
Auburn, AL 36849

Research Website
 

Huber Research Lab

Education

 

PhD, Department of Large Animal Medicine, University of Georgia, USA. Focused on molecular epidemiology of antimicrobial resistance
DVM, Federal University of Santa Maria, Brazil

Biography

 

Dr. Huber received her DVM from the Federal University of Santa Maria in the south of Brazil in 2012, her MSc in the Federal University of Rio Grande do Sul in 2017, and her PhD at University of Georgia in 2019.

After graduating as DVM, she has worked as a resident veterinarian at a horse breeding farm, and as a field veterinarian focused mostly on dairy cattle management. She completed a fellowship program at Hagyard Equine Medicine Institute in Lexington Kentucky in 2014, where she worked in equine medicine and neonatology.

She moved to Zurich, Switzerland in 2020 for a postdoctoral program at ETH, where she focused on understanding the spatial epidemiology of antimicrobial resistance spread in foodborne pathogens.

In January 2021, Dr. Huber joined Auburn University as an assistant professor of epidemiology at the Department of Pathobiology, College of Veterinary Medicine

Research Interests

 

Her molecular epidemiology laboratory located at Greene Hall 251E is focused on understanding contribution of the animal-human-environment interactions on the spread and maintenance of antimicrobial resistance. At her lab, her group explores the effects of policies to reduce antimicrobial use in the food- and companion- animal industries on development of resistance in the environment and the potential of human contamination with resistant pathogens. They use a molecular, epidemiological, socio-economical approach to understand the global implications of antimicrobial resistance in animal, human, and environmental health.

Publications

 

Huber, L., Bordin, A. I., Sanz, M. G. & Cohen, N. D. Rhodococcus equi foal pneumonia: Update on epidemiology, immunity, treatment and prevention. Equine Vet. J. evj.13567 2022.

Huber, L., Agunos, A., Gow, S. P., Carson, C. A. & Van Boeckel, T. P. Reduction in Antimicrobial Use and Resistance to Salmonella , Campylobacter , and Escherichia coli in Broiler Chickens, Canada, 2013–2019. Emerg. Infect. Dis. 27, 2434–2444 2021.

Huber L., Ström Hallenberg G., et al. Geographic drivers of antimicrobial use and resistance in pigs in Khon Kaen province, Thailand. Frontiers in Veterinary Science 2021.

Huber L., Álvarez-Narvàez S., et al. Epidemiology and molecular basis of multidrug resistance in Rhodococcus equi. Microbiology and Molecular Biology Reviews 2021.

Huber L., Giguère S., et al. Association between antimicrobial treatment of subclinical pneumonia in foals and selection of macrolide- and rifampicin- resistant Rhodococcus equi strains at horse-breeding farms in central Kentucky. JAVMA 2021;258(6):648-653.

Tiseo K., Huber L., et al.  Global trends in antimicrobial use in food animals from 2017 to 2030. Antibiotics 2020;9(12):918.

Huber L., Giguère S., et al. The novel and transferable erm(51) gene confers Macrolides, Lincosamides, and Streptogramins B (MLSB ) resistance to clonal Rhodococcus equi in the environment. Environ Microbiol 2020.

Huber L., Giguère S., et al. Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA. Vet Microbiol 2019; 235:243-247.

Huber L., Giguere S., Cohen ND, et al. Identification of macrolide- and rifampicin-resistant Rhodococcus equi in environmental samples from equine breeding farms in central Kentucky during 2018. Vet Microbiol 2019;232:74-78.

Huber L., Giguere S., et al. Fecal shedding of Rhodococcus equi in mares and foals after experimental infection of foals and effect of composting on concentrations of R. equi in contaminated bedding. Vet Microbiol 2018;223:42-46.

Huber L., Giguere S., et al. Emergence of resistance to macrolides and rifampicin in clinical isolates of Rhodococcus equi from foals in central Kentucky, USA: 1995 to 2017. Antimicrob Agents Chemother 2018.

Huber L., Giguère S., et al. Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi. PLoS ONE 2018. 13(2): e0192655.

Huber L., Gressler L.T., et al. Monitoring Foals by Thoracic Ultrasonography, Bacterial Culture, and PCR: Diagnostic of Rhodococcus equi Subclinical Pneumonia in South of Brazil. Journal of Equine Veterinary Science, Volume 60, 104 – 108.

Book chapters:

Huber L. and Giguère S. Rhodococcus equi infections, 2018. JAW Coetzer and P Oberem (Directors) In: Infectious Diseases of Livestock, JAW Coetzer, GR Thomson, NJ Maclachlan and M-L Penrith (Editors).

Thesis:

Huber L. Monitoramento de potros por ultrasonografia torácica, cultura bacteriológica e pcr: diagnóstico de infecção subclínica por Rhodococcus equi. Master in Equine Medicine Thesis, Universidade Federal do Rio Grande do Sul, 2016.

Dissertation:

Huber L. Epidemiology and Genetic Mechanisms of Macrolide and Rifampicin Resistance in Isolates of Rhodococcus equi at Horse Breeding Farms in Kentucky. PhD in Comparative Biomedical Sciences, University of Georgia, 2019.

Dr. Huber on Research Gate

Dr. Huber on ORCID